197 related articles for article (PubMed ID: 33418509)
1. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
[TBL] [Abstract][Full Text] [Related]
2. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R
J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874
[TBL] [Abstract][Full Text] [Related]
3. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
[TBL] [Abstract][Full Text] [Related]
4. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
[TBL] [Abstract][Full Text] [Related]
5. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants.
Van Emburgh BO; Robertson KD
Nucleic Acids Res; 2011 Jul; 39(12):4984-5002. PubMed ID: 21378119
[TBL] [Abstract][Full Text] [Related]
7. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
[TBL] [Abstract][Full Text] [Related]
8. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
[TBL] [Abstract][Full Text] [Related]
9. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA
Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527
[TBL] [Abstract][Full Text] [Related]
10. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases.
Gowher H; Jeltsch A
J Biol Chem; 2002 Jun; 277(23):20409-14. PubMed ID: 11919202
[TBL] [Abstract][Full Text] [Related]
11. Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions.
Nowialis P; Lopusna K; Opavska J; Haney SL; Abraham A; Sheng P; Riva A; Natarajan A; Guryanova O; Simpson M; Hlady R; Xie M; Opavsky R
Nat Commun; 2019 Sep; 10(1):4374. PubMed ID: 31558711
[TBL] [Abstract][Full Text] [Related]
12. Requirement of DNMT1 to orchestrate epigenomic reprogramming for NPM-ALK-driven lymphomagenesis.
Redl E; Sheibani-Tezerji R; Cardona CJ; Hamminger P; Timelthaler G; Hassler MR; Zrimšek M; Lagger S; Dillinger T; Hofbauer L; Draganić K; Tiefenbacher A; Kothmayer M; Dietz CH; Ramsahoye BH; Kenner L; Bock C; Seiser C; Ellmeier W; Schweikert G; Egger G
Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33310759
[TBL] [Abstract][Full Text] [Related]
13. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells.
Agarwal S; Amin KS; Jagadeesh S; Baishay G; Rao PG; Barua NC; Bhattacharya S; Banerjee PP
Mol Cancer; 2013 Aug; 12(1):99. PubMed ID: 24001151
[TBL] [Abstract][Full Text] [Related]
14. Global identification of genes targeted by DNMT3b for epigenetic silencing in lung cancer.
Teneng I; Tellez CS; Picchi MA; Klinge DM; Yingling CM; Snider AM; Liu Y; Belinsky SA
Oncogene; 2015 Jan; 34(5):621-30. PubMed ID: 24469050
[TBL] [Abstract][Full Text] [Related]
15. MN1 overexpression is driven by loss of DNMT3B methylation activity in inv(16) pediatric AML.
Larmonie NSD; Arentsen-Peters TCJM; Obulkasim A; Valerio D; Sonneveld E; Danen-van Oorschot AA; de Haas V; Reinhardt D; Zimmermann M; Trka J; Baruchel A; Pieters R; van den Heuvel-Eibrink MM; Zwaan CM; Fornerod M
Oncogene; 2018 Jan; 37(1):107-115. PubMed ID: 28892045
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase 3B (DNMT3B) mutations in ICF syndrome lead to altered epigenetic modifications and aberrant expression of genes regulating development, neurogenesis and immune function.
Jin B; Tao Q; Peng J; Soo HM; Wu W; Ying J; Fields CR; Delmas AL; Liu X; Qiu J; Robertson KD
Hum Mol Genet; 2008 Mar; 17(5):690-709. PubMed ID: 18029387
[TBL] [Abstract][Full Text] [Related]
17. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.
Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R
Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767
[TBL] [Abstract][Full Text] [Related]
18. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E
Wong CC; Kang W; Xu J; Qian Y; Luk STY; Chen H; Li W; Zhao L; Zhang X; Chiu PW; Ng EK; Yu J
Theranostics; 2019; 9(21):6256-6268. PubMed ID: 31534549
[No Abstract] [Full Text] [Related]
20. Pivotal role for S-nitrosylation of DNA methyltransferase 3B in epigenetic regulation of tumorigenesis.
Okuda K; Nakahara K; Ito A; Iijima Y; Nomura R; Kumar A; Fujikawa K; Adachi K; Shimada Y; Fujio S; Yamamoto R; Takasugi N; Onuma K; Osaki M; Okada F; Ukegawa T; Takeuchi Y; Yasui N; Yamashita A; Marusawa H; Matsushita Y; Katagiri T; Shibata T; Uchida K; Niu SY; Lang NB; Nakamura T; Zhang KYJ; Lipton SA; Uehara T
Nat Commun; 2023 Feb; 14(1):621. PubMed ID: 36739439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
